Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Guideline
. 2020 Mar;18(3):230-241.
doi: 10.6004/jnccn.2020.0012.

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

John A Thompson  1 , Bryan J Schneider  2 , Julie Brahmer  3 , Stephanie Andrews  4 , Philippe Armand  5 , Shailender Bhatia  1 , Lihua E Budde  6 , Luciano Costa  7 , Marianne Davies  8 , David Dunnington  9 , Marc S Ernstoff  10 , Matthew Frigault  11 , Benjamin H Kaffenberger  12 , Matthew Lunning  13 , Suzanne McGettigan  14 , Jordan McPherson  15 , Nisha A Mohindra  16 , Jarushka Naidoo  3 , Anthony J Olszanski  17 , Olalekan Oluwole  18 , Sandip P Patel  19 , Nathan Pennell  20 , Sunil Reddy  21 , Mabel Ryder  22 , Bianca Santomasso  23 , Scott Shofer  24 , Jeffrey A Sosman  16 , Yinghong Wang  25 , Ryan M Weight  26 , Alyse Johnson-Chilla  27 , Griselda Zuccarino-Catania  27 , Anita Engh  27
Affiliations
Guideline

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

John A Thompson et al. J Natl Compr Canc Netw. 2020 Mar.

Abstract

The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe symptoms that may be caused by an irAE and should trigger further investigation, and summarize the NCCN Management of Immunotherapy-Related Toxicities Panel discussions for the 2020 update to the guidelines regarding immune checkpoint inhibitor-related diarrhea/colitis and cardiovascular irAEs.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources